OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic
Seyed Alireza Javadinia, Mona Ariamanesh, Maryam Nabavifard, et al.
Cancer Investigation (2021) Vol. 40, Iss. 2, pp. 115-123
Closed Access | Times Cited: 20

Showing 20 citing articles:

COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety
Seyed Alireza Javadinia, Kimia Alizadeh, Mohammad‐Shafi Mojadadi, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 30

COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status
Zhujun Cao, Chenxi Zhang, Shuang Zhao, et al.
Infectious Diseases of Poverty (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 18

Clinical Characteristics and Outcomes of COVID-19 in 1294 New Cancer Patients: Single-Center, Prospective Cohort Study from Iran
Danial Fazilat‐Panah, Hamid Fallah Tafti, Yavar Rajabzadeh, et al.
Cancer Investigation (2022) Vol. 40, Iss. 6, pp. 505-515
Closed Access | Times Cited: 13

Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis
Juntao Yin, Yangyang Chen, Yang Li, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 7

Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population
Amin Moradi Hasan‐Abad, Mohsen Arbabi, Hamidreza Gilasi, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 1

Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients
Yash Shah, Stephanie Kjelstrom, Diana Martinez, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 3577-3588
Open Access | Times Cited: 6

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer
Tong Li, Rui Song, Jingjie Wang, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 874-884
Open Access | Times Cited: 4

COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19)
Ke Zhou, Jean‐Luc Raoul, Audrey Blanc-Lapierre, et al.
Clinical Medicine Insights Oncology (2022) Vol. 16
Open Access | Times Cited: 3

A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers
Haoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
Heliyon (2022) Vol. 8, Iss. 9, pp. e10583-e10583
Open Access | Times Cited: 3

SARS-CoV-2 antibody response after BBIBP-CorV (Sinopharm) vaccination in cancer patients: A case-control study
Fahimeh Safarnezhad Tameshkel, Shabnam Abedin Dargoush, Bahareh Amirkalali, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 1

Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer
Yuling Han, Jiaxin Yang, Danshuang He, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 2

COVID-19 vaccination in patients with cancer: Opportunities and challenges
Zahraa Haleem Al‐qaim, Hasanain Kamil Hasan Owadh, Sarah A. Ali, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 2

Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study
Kyoungmin Lee, In Hae Park, Sang Cheul Oh, et al.
Cancer Medicine (2022) Vol. 12, Iss. 5, pp. 5558-5568
Open Access | Times Cited: 2

A year of experience with COVID‐19 in patients with cancer: A nationwide study
Mina Khosravifar, Sogol Koolaji, Negar Rezaei, et al.
Cancer Reports (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 1

The Effects of the COVID-19 Pandemic in Oncology Patient Management
Mário Forrester, Luiza Breitenfeld, Miguel Castelo-Branco, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 15, pp. 9041-9041
Open Access

Antigen rapid diagnostic test monitoring for SARS‐CoV‐2 in asymptomatic and fully vaccinated cancer patients: Is it cost‐effective?
Mario Caccese, Anna Maria Saieva, Valentina Guarneri, et al.
Cancer Medicine (2022) Vol. 12, Iss. 7, pp. 7795-7800
Open Access

Page 1

Scroll to top